reagent tablets in 1941, Bayer has led the way in diabetes
care product innovation. The company changed the face of diabetes care in
1969 when it introduced the first portable blood glucose meter and test
strips. Bayer HealthCare further innovated diabetes management by being the
first company to introduce a suite of blood glucose monitors with No
Coding(TM) technology. The BREEZE(R)2 and CONTOUR(R) blood glucose
monitoring systems offer people with diabetes an unparalleled choice in
diabetes management systems. The Arthritis Foundation in the United States
and the Arthritis Society of Canada each granted Ease-of Use Commendation
to the BREEZE(R)2 meter. BREEZE(R) represents the first time a blood
glucose meter has been recognized as easy to use for arthritis sufferers.
In July 2006, Bayer Diabetes Care acquired Metrika Inc., maker and
manufacturer of A1CNow+, a meter-based diabetes monitoring system for
measurement of A1C (glycated hemoglobin) an important indicator of long
term blood sugar control. Bayer HealthCare, Diabetes Care global
headquarters is located in Tarrytown, New York, in the United States and
operates as part of Bayer HealthCare LLC, a member of the worldwide Bayer
HealthCare group. http://www.bayerdiabetes.com/us
Bayer HealthCare
Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's
leading, innovative companies in the healthcare and medical products
industry and is based in Leverkusen, Germany. The company combines the
global activities of the Animal Health, Consumer Care, Diabetes Care and
Pharmaceuticals divisions. The pharmaceuticals business operates under the
name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and
manufacture products that will improve human and animal health worldwide.
This news release contains forward-looking statements based on current
assumptions and forecasts made by Bayer Group management. Various know
'/>"/>
SOURCE Bayer Diabetes Care Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
Photos: Bayer Names New U.S. CEO2.
Bayer USA Foundation Supports Summer Science Education Programs in Pittsburgh, Raleigh, Houston and Tyler, Texas3.
Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives4.
Statement From Bayer(R) Aspirin Regarding the American Medical Associations New Aspirin Policy Resolution5.
Bayer Announces Availability of Reformulated Liquid Leukine(R)6.
ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare7.
United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Childrens Painting Competition8.
Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia9.
Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement10.
Bayer to Receive Two Top National Awards for Its Science Education, Science Literacy Work11.
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement